C ornea is one of the most transparent tissues in the body, and a substantial number of genes contribute to the attainment and maintenance of the specific properties of this tissue. 1, 2 Recent advances in molecular biology have allowed us to understand corneal physiology and disease at the molecular level. One of the prominent events in this research area is the discovery of the transforming growth factor, ␤-induced (TGFBI) gene as a causative gene in five classic autosomal dominant corneal dystrophies. 3 Subsequently, other types of inherited corneal dystrophies, such as Meesmann corneal dystrophy (MECD) 4, 5 and gelatinous droplike corneal dystrophy (GDLD), 6, 7 have been reported. Lattice corneal dystrophy (LCD) is characterized by stromal amyloid depositions that typically appear as a network or lattice. LCD type I (LCD1) is one of the five dominant TGFBI-related corneal dystrophies with characteristic latticelike refractile lines within the corneal stroma. 8 Other than this common LCD, several minor ones have been reported in the TGFBI gene (currently designated as Variant LCD in the IC3D classification) that are caused by different mutations. 9 LCD type IV (LCD4, a variant LCD) is one such corneal dystrophy first reported in 1998 as a late-onset LCD with characteristic amyloid depositions located at the deep stromal layer of cornea. 10 Although LCD1 has been reported world-wide, 3, 11 LCD4 has been reported only in the Japanese population. [12] [13] [14] [15] [16] [17] [18] [19] Thus, some researchers have theorized that LCD4 may be caused by a founder mutation that occurred in a Japanese ancestor. 20 In this study, we performed a haplotype analysis on genomic DNA samples obtained from 13 patients with LCD4 to investigate this theory. We found that all the disease-carrying alleles of the investigated 13 LCD4 patients shared an identical haplotype around its causative mutation, whereas healthy alleles exhibited four haplotypes with no apparent preference. These data strongly suggest that all LCD4 mutations descend from a founder mutation that occurred in a single Japanese ancestor.
MATERIALS AND METHODS

Human Samples
Peripheral blood was obtained from 13 patients from 13 unrelated families who had received a clinical diagnosis of LCD4. These 13 patients were 7 men and 6 women, ranging in age from 52 to 83 years (mean age, 69.8). Seven resided in Kyoto, one in Osaka, one in Mie, one in Niigata, one in Kanagawa, and two in Tokyo Prefecture (Fig. 1) . Genomic DNA samples from 96 normal Japanese volunteers (48 men and 48 women) were obtained from a research-resource bank (Human Science Research Resource Bank, Osaka, Japan). Written informed consent was obtained from all patients after they were given a detailed explanation of the study protocols. The study adhered to the tenets of the Declaration of Helsinki and was approved by the Institutional Committee for Ethical Issues at Kyoto Prefectural University of Medicine. 
Haplotype Analysis
Genomic DNA samples were amplified by PCR using a primer pair (exon12_F and exon13_R; Table 1 ) against a genomic region between exon 12 and 13 of the TGFBI gene, which harbors the site of the c.1580TϾG mutation and six known SNPs (Fig. 2 , Table 2 ). The amplified products were then electrophoresed on a 1% agarose gel, excised, purified with a commercially available column-based purification kit (Wizard SV Gel and PCR Clean-Up System; Promega, Madison, WI), and ligated to a TA-cloning vector (pGEM-T Easy Vector; Promega). The plasmid vector was transformed into chemically competent Escherichia coli cells (competent high JM-109; Toyobo Co., Ltd., Osaka, Japan) and seeded on a 1% LB agar plate supplemented with IPTG and X-gal for the standard bluewhite selection. After 24 hours' incubation, 16 white colonies were picked from each sample and isothermally amplified overnight with a phi29 polymerase-based plasmid amplification kit (Illustra TempliPhi DNA Amplification Kit; GE Health Care). Each of the amplified products was then subjected to a 1-base primer extension assay (SNaPshot; ABI) with seven pooled primers (Table 1 ) against the sites of the mutation and the six known SNPs. After treatment with shrimp alkaline phosphatase, the assay products were electrophoresed on the automated sequencer, and the data were analyzed with the use of commercially available software (GeneMapper Software; ABI). Because artificial recombination presumably occurring during the PCR amplification and the bacterial transformation is not negligible in this analysis, a Perl-based program (HapTyper.pl) was created to estimate the most probable haplotype pair from the processed data for each sample.
Statistical Analysis
For the identification of the statistical significance in the haplotype distribution between the affected alleles and the nonaffected alleles, 2 and Fisher's exact tests were performed with commercially available statistical software (SAS ver. 9.1; SAS Institute Inc., Cary, NC). For the calculation of statistical power, R language (R Foundation, Vienna, Austria) was used.
RESULTS
The enrolled 13 LCD4 patients, except for 1 patient, exhibited similar corneal haze composed of isolated or fused refractile opacities, most of them being dotlike, and some being latticelike. Most important, these depositions were mainly located within the deep stromal layer, which seems to be specific to this disease and of great diagnostic value, as reported previously. Sequencing analysis revealed that all the 13 LCD4 patients enrolled in this study exhibited a substitution mutation (T to G; c.1580TϾG), resulting in an amino acid transition from leucine to arginine (p.Leu527Arg; Fig. 3 ). Only one patient (59-year-old woman) was homozygous for the mutation site, and she exhibited a much more severe corneal phenotype than did other patients heterozygous for the mutation, such as another homozygous LCD4 patient detailed in a previous report. 19 One patient had a heterozygous substitution mutation from A to G at a different nucleotide position (c.1631AϾG) that results in an amino acid transition from asparagine to serine (p.Asn544Ser), which has already been reported to be causative of another type of variant LCD. 17, 20, 21 In this patient, these two mutations were located on different alleles from one another, as determined by subsequence haplotype analysis (data not shown).
Haplotype analysis was performed to examine whether the combination of the six SNPs, which are close to the c.1580TϾG mutation and hence show a strong linkage disequilibrium to that mutation site, was identical among the disease- 
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The amplified region is illustrated in Figure 2 . * SNPs investigated.
carrying alleles of the 13 LCD4 patients. As expected, all the 14 (12 heterozygous plus 1 homozygous) disease-carrying alleles found in the patients demonstrated an identical SNP-haplotype (Table 3) . Two of the 12 healthy alleles from the patients exhibited the same SNP-haplotype as found in the diseasecarrying alleles. Three different haplotypes were also found in the healthy alleles. A random cross section of normal volunteers was also examined to investigate which haplotypes are 
.1580 is the site of causative mutation in LCD4, where T means wild-type and G means mutated-type. All disease-carrying alleles shared an identical SNP haplotype (T-G-T-T-A-T). Note that patient LCD4_10 had c.1580TϾG mutations in both alleles. dominant in the current Japanese population. Among the 96 normal samples, 91 produced data with sufficient quality for the subsequent analysis, but data from the other 5 samples were omitted due to insufficient quality. In the 91 normal samples, four haplotypes were found, which were identical with those found in the healthy alleles of the LCD4 patients. Of those, the mutation-related haplotype (T-G-T-T-A-T) appeared the most abundant (65/182; 35.7%) in the current Japanese population (Table 4) . Statistical significance was found (P ϭ 0.00003, 2 test, or P ϭ 0.00002, Fisher's exact test) in difference between the haplotype distribution in the disease-carrying and the healthy alleles. The statistical power for our enrolled samples was 1 at the 0.05 level of significance.
DISCUSSION
Allelic homogeneity is a prominent feature of the TGFBI-related corneal dystrophies. 22, 23 This fact can be well explained by two different mechanisms: the first is the presence of mutation hot spots, 24 and the second is a founder mutation. The mutation hot spots are mainly located at cytosine or guanine within CpG dinucleotides. Cytosine within the CpG dinucleotide is frequently modified by methylation (5-methylated cytosine; 5meC) in mammalian cells, mainly for epigenetic regulation. 25 The 5meC can be spontaneously deaminated, thus producing thymine which results in CϾT or GϾA conversion when the deamination occurs in a sense or antisense strand, respectively. 26 Although a DNA mismatch-repair mechanism normally recognizes and repairs such heteroduplex sites, 27 the conversions are occasionally passed over unnoticed, possibly due to the insufficient stringency of the repair mechanism. Eventually, when such a conversion occurs in a germ-line cell, the CϾT or GϾA conversions can be inherited over generations.
Within the spectrum of TGFBI-related corneal dystrophies, LCD1 and granular corneal dystrophy type 1 (GCD1) are caused by the CϾT conversion, granular corneal dystrophy type 2 (GCD2, alternatively designated as Avellino corneal dystrophy) and Thiel-Behnke corneal dystrophy (TBCD) 28 are caused by the GϾA conversion, with all these conversions occurring at CpG sites (Table 5) . Therefore, it is strongly supposed that these four dominant TGFBI-related corneal dystrophies are caused by that mutation mechanism. In actuality, these dystrophies occur at a relatively high frequency in many countries, thus implicating the existence of multiple, independently occurring founders, in different areas of the world.
Apart from the mutation mechanism, other types of mutations, including non-CϾT or non-GϾA mutations or CϾT or GϾA mutations occurring at non-CpG sites, sometimes occur. Such types of mutations seem to be mainly caused by the accidentally occurring replication error during cell division that may escape the proofreading function of DNA polymerase, as well as the DNA mismatch-repair process, with a roughly estimated frequency of 1 in 10 9 to 10 10 base pairs per cell division. 27 Hence, these mutations are predisposed to be much less frequent and tend to become a founder mutation. Other than the four dominant TGFBI-related corneal dystrophies described earlier, those including LCD4 clearly meet the criteria for this mutation mechanism (Table 5 ). In fact, most of these corneal dystrophies occur infrequently and are reported in only one, or at most, only a few countries. For example, in the Japanese population, founder mutations have been reported in corneal dystrophies of LCD type IIIA 23 (currently designated as variant LCD in the IC3D classification), GCD2, 22 and GDLD with a p.Gln118X mutation. 7 Our current haplotype analysis of the 13 LCD4 patients revealed that all their disease-carrying alleles share an identical SNP-haplotype. Since the residences of the 13 patients were not restricted to a small geographic area, but in fact, extended across six different prefectures in Japan (Fig. 1) , such biased data seem to be ascribed, not to the preference of a certain SNP-haplotype that was due to a bias toward their place of residence, but rather to the occurrence of a founder mutation in a Japanese ancestor. We imagine that almost all infrequently occurring corneal dystrophies may have been related to the occurrence of founder mutations.
One exception to the hypothesis for the occurrence of a mutation among the TGFBI-related corneal dystrophies appears to be Reis-Bückler's corneal dystrophy (RBCD). The mutation of RBCD is located on the same CpG site as that of LCD1 and GCD2 but its substitution is GϾT, not CϾT or GϾA. Therefore, the cause of mutation in RBCD seems to be a simple replication error not a deamination. However, RBCD has been reported in many countries, similar to the other four dominant TGFBI-related corneal dystrophies. Therefore, the exact mechanism for the occurrence of the RBCD mutation cannot be explained by our hypothesis, but it is hoped that it will be elucidated in the future. We performed a 1-base primer extension assay for the identification of the SNP-haplotype. The reason we chose that method rather than the standard sequencing analysis is that the former method can be easily multiplexed and hence largely save time and costs compared with the latter method. In addition, a commercially available phi29 polymerase-based, isothermal plasmid amplification procedure has been developed. 29 This procedure is much more time-efficient than the standard plasmid DNA extraction procedure and has been subjected to various applications. 30 -33 Thus, we examined whether the phi29 polymeraseamplified plasmid DNA can also be used as the template for the 1-base primer extension assay. As is shown in Figure 4 , the chromatogram data of this combined assay was of sufficient quality for the identification of each of the SNPs examined in this study. We think that this combined procedure is quite useful for experimentally determining haplotypes.
We initially expected that data from the 16 plasmids investigated for each sample could be easily divided into one or two haplotype groups without any confusion. However, the actual data were sometimes quite complicated, possibly due to the artificial recombination during the consecutive processes of PCR and bacterial transformation, as reported previously. 34 In that study, a method of eliminating such an artificial recombination was also reported. However, although we performed an additional three-cycle PCR amplification against a 10-times diluted initial PCR product, according to this reconditioning PCR method, the artificial recombination was still observed, possibly due to the insufficiency of the reconditioning PCR. For example, a mutation/ Fig. 4 ). Therefore, we created a Perl-based software program, to identify the most probable haplotype pair by calculating a score for each of the possible haplotypes estimated from the genotype data of each sample. We carefully reviewed the processed data and found that the software worked properly. We think that this software may be useful for studies conducted in the future that are similar to the present study.
SNP-combination T-T-G-T-T-A-C was observed in a normal volunteer who was found to have two haplotypes (T-T-G-T-C-A-C and T-T-G-T-T-A-T;
In summary, our findings indicate that LCD4 was caused by a founder mutation that occurred in a single Japanese ancestor. In addition, we have established a time-and cost-efficient new procedure through the combination of an isothermal amplification of plasmid DNA and a 1-base primer extension assay. We created a Perl-based software program that helps estimate the most probable haplotype pair from blended data hampered by randomly occurring artificial recombinations. We hope that the results of this study, as well as the newly developed procedures, will contribute to the further understanding of the etiology, populational genetics, and pathogenesis of inherited dystrophies of the cornea and of other organs.
